Key facts
- Jeff Elliott has notified Sera Prognostics of his departure from the board of directors.
- Elliott has served on the board since 2021.
- Sera Prognostics is focused on improving maternal and neonatal health.
Sera Prognostics, a company dedicated to enhancing maternal and neonatal health through advanced pregnancy biomarker information, is undergoing a board transition. The departure of a long-serving member signals potential shifts in governance or strategic direction.